DELCATH SYSTEMS, INC. Debt Securities, Available-for-sale, Amortized Cost
DELCATH SYSTEMS, INC. (DCTH) had Debt Securities, Available-for-sale, Amortized Cost of $15.20 million as of 2024-03-31, per its 10-Q filed 2024-05-14.
Discontinued › Notes › Credit Losses
us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis · last filed 2024-05-14
- 2024-03-31: Debt Securities, Available-for-sale, Amortized Cost $15.20M.
- 2023-12-31: Debt Securities, Available-for-sale, Amortized Cost $19.65M.
| Period end | Debt Securities, Available-for-sale, Amortized Cost |
|---|---|
| 2024-03-31 | $15.20M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $19.65M 10-Q · filed 2024-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| CARLSMED, INC. (CARL) | United States | $0.405B |